Articles Accepted

MOLECULAR DOCKING OF PHYTOCONSTITUENTS TO EVALUATE ANTIVIRAL EFFECTIVENESS AGAINST NIPAH VIRUS ATTACHMENT GLYCOPROTEIN
by Dr. Saranya T S, 29 Nov 2024

Nipah virus is a biosafety level 4 pathogen with a high fatality rate, making it a critical research priority. Despite the use of synthetic compounds like Ribavirine, Remdesivir, and Favipiravir, there is a growing interest in using natural molecules as antiviral agents. Molecular docking studies were conducted to evaluate the antiviral capabilities of isolated compounds from plant species Alstonia scholaris, Picrorhiza kurroa, Swertia chirata, Caesalpinia crista against the Nipah virus attachment glycoprotein. 171 compounds were selected and subjected to screening processes such as Lipinski rule of 5, ADME and toxicity prediction from which 46 compounds were selected for molecular docking against 2VSM using EasyDockVina. The compounds were compared to the standard drug Ribavirine (-7.4kcal/mol) and found that 35 compounds have a binding score greater than Ribavirine. 7-acetoxybonducellpin C and Caesalpinin I showed the highest binding affinity -10.2Kcal/mol. These compounds could be a potential lead for developing new therapeutic agents.

Current Issue
March 2025
Quick Contact